| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
1990-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fbcde30384331bfcda738963a05f06e |
| publicationDate |
1991-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0445280-A1 |
| titleOfInvention |
MEDICINE AND METHOD FOR INHIBITING VASCULARIZATION OF TUMORS. |
| abstract |
Therapeutic method and agent at least partially inhibiting the vascularization of an active full tumor. The therapeutic agent comprises a polysaccharide toxin, a GBS toxin, produced by the group B beta-hemolytic Streptococcus bacteria. The GBS agent is in the form of a purified active toxin which can be administered parenterally at an effective dose inhibiting the vascularization. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939396-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609614-B2 |
| priorityDate |
1989-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |